Tempus AI, Inc (BMV: TEM)

Market Cap	164.95B
Revenue (ttm)	12.54B
Net Income (ttm)	-15.68B
Shares Out	n/a
EPS (ttm)	-166.85
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28
Average Volume	74
Open	1,030.61
Previous Close	1,070.00
Day's Range	1,000.00 - 1,030.61
52-Week Range	800.00 - 1,070.00
Beta	n/a
RSI	n/a
Earnings Date	Apr 25, 2025

About Tempus AI

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to ph...

• Industry: Medical Laboratories
• Founded: 2015
• Employees: 1,500
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: TEM

Financial Performance

In 2023, Tempus AI's revenue was $531.82 million, an increase of 65.85% compared to the previous year's $320.67 million. Losses were -$265.96 million, -20.35% less than in 2022.

Financial numbers in USD